DXCM
DexCom Inc
89.40$
+1.6%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +55.1% | +42.6% | +25.3% | +43.6% | +43.1% | +30.5% | +27.1% | +18.8% | +24.5% | +11.3% | +15.6% | |
| – | +49.1% | +57.7% | +16.2% | +62.4% | +48.1% | +18.8% | +18.8% | +33.7% | +29.9% | +19.6% | +16.6% | |
| – | +57.9% | +35.9% | +30.0% | +34.9% | +40.3% | +37.4% | +31.3% | +12.1% | +21.5% | +6.5% | +14.9% | |
| – | +98.1% | +13.5% | +18.8% | +125.1% | -34.5% | +31.6% | +67.9% | -19.9% | +4.5% | +9.2% | +8.5% | |
| – | +54.2% | +38.5% | +19.3% | +24.9% | +18.1% | +12.8% | +25.7% | +26.8% | +15.8% | +8.7% | +18.3% | |
| – | +69.6% | +31.8% | +20.9% | +59.0% | -7.2% | +24.3% | +44.3% | +5.5% | +13.4% | +8.7% | +2.8% | |
| – | – | – | – | – | – | +110.5% | -11.3% | +47.2% | +52.8% | +0.4% | +52.0% | |
| – | -50.0% | +75.0% | +1,728.6% | +77.3% | +165.6% | +40.5% | -77.8% | -1.1% | +9.1% | -6.4% | -3.7% | |
| – | – | – | – | – | – | +115.9% | +14.1% | +52.2% | +81.8% | -0.2% | +53.5% | |
| – | +0.0% | +600.0% | +128.6% | -62.5% | +416.7% | -8,764.5% | – | +24.3% | +240.5% | -21.4% | +89.8% | |
| – | – | – | – | – | – | +388.2% | -56.1% | +57.3% | +58.7% | +6.4% | +45.1% | |
| – | – | – | – | – | – | +76.7% | +0.2% | +49.7% | +62.2% | +3.2% | +43.7% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.